Breaking News

You are here » Indian-Commodity  :  Mutual Funds  :  UTI Mutual Fund introduces Fixed Term Income Fund Series XXVIII-XV (1147 Days)

02-Apr2018

UTI Mutual Fund introduces Fixed Term Income Fund Series XXVIII-XV (1147 Days)

UTI Mutual Fund has launched the UTI Fixed Term Income Fund Series XXVIII-XV (1147 Days), a close ended income scheme. The NFO opens for subscription on April 02, 2018 and closes on April 03, 2018. No entry load and exit load will be applicable for the scheme. The minimum subscription amount is Rs 5000.

The investment objective of the scheme is to generate returns by investing in portfolio of fixed income securities maturing on or before the date of maturity of the scheme.


Related News

View all news

Aditya Birla Sun Life Mutual Fund introduces Fixed Term Plan-Series QQ (1100 days)

Aditya Birla Sun Life Mutual Fund has launched the Aditya Birla Sun Life Fixed Term Plan-Series QQ (1100 days), a close ended income scheme. The NFO opens for subscription on August 20, 2018 and closes......

Franklin Templeton Mutual Fund introduces Fixed Maturity Plans-Series 4-Plan C (1098 days)

Franklin Templeton Mutual Fund has launched the Franklin India Fixed Maturity Plans-Series 4-Plan C (1098 days), a close ended income scheme. The NFO opens for subscription on August 20, 2018 and closes......

Reliance Mutual Fund introduces Fixed Horizon Fund XXXVIII-Series 14

Reliance Mutual Fund has launched the Reliance Fixed Horizon Fund XXXVIII-Series 14, a close ended income scheme. The NFO opens for subscription on August 20, 2018 and closes on August 23, 2018. No entry......

Top News

View all news

Tijaria Polypipes bags order worth Rs 35.30 crore

Tijaria Polypipes has received a single order of Rs 35.30 crore for supply of HDPE & PLB Ducts from Tata Projects. The same has to be executed within a period of 3 months. The company takes great......

RIL's telecom arm enters into 5 year partnership with Star India

Reliance Industries' (RIL) telecom arm -- Reliance Jio Infocomm (Jio) -- has entered into 5 year partnership with India's leading broadcaster, Star India to unleash a new era in sports entertainment. Jio......

Sun Pharma receives Australian TGA approval for ILUMYA

Sun Pharmaceutical Industries has received the Australian Therapeutic Goods Administration (TGA) approval for its specialty product, ILUMYA (tildrakizumab) for the treatment of adults with moderate-to-severe......